Report cover image

Global Microfluidic Devices For MPS (Microphysiological Systems) Market Growth 2025-2031

Published Aug 15, 2025
Length 82 Pages
SKU # LPI20313112

Description

The global Microfluidic Devices For MPS (Microphysiological Systems) market size is predicted to grow from US$ 380 million in 2025 to US$ 505 million in 2031; it is expected to grow at a CAGR of 4.9% from 2025 to 2031.

Microfluidic devices for MPS (Microphysiological Systems) are miniaturized platforms that simulate the complex physiological conditions of human tissues and organs. These devices use micro-scale fluid channels and chambers to replicate biological environments, enabling researchers to study cellular behavior, drug responses, and disease mechanisms in a controlled and reproducible way.

United States market for Microfluidic Devices For MPS (Microphysiological Systems) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Microfluidic Devices For MPS (Microphysiological Systems) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Microfluidic Devices For MPS (Microphysiological Systems) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Microfluidic Devices For MPS (Microphysiological Systems) players cover Emulate, Mimetas, uFluidix, Organovo, TissUse, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Microfluidic Devices For MPS (Microphysiological Systems) Industry Forecast” looks at past sales and reviews total world Microfluidic Devices For MPS (Microphysiological Systems) sales in 2024, providing a comprehensive analysis by region and market sector of projected Microfluidic Devices For MPS (Microphysiological Systems) sales for 2025 through 2031. With Microfluidic Devices For MPS (Microphysiological Systems) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Microfluidic Devices For MPS (Microphysiological Systems) industry.

This Insight Report provides a comprehensive analysis of the global Microfluidic Devices For MPS (Microphysiological Systems) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Microfluidic Devices For MPS (Microphysiological Systems) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Microfluidic Devices For MPS (Microphysiological Systems) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microfluidic Devices For MPS (Microphysiological Systems) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Microfluidic Devices For MPS (Microphysiological Systems).

This report presents a comprehensive overview, market shares, and growth opportunities of Microfluidic Devices For MPS (Microphysiological Systems) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Straight Channel
Y Channel
T-Joint
Other

Segmentation by Application:
Drug Discovery
Disease Modeling
Toxicology
Personalized Medicine
Organs On A Chip
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Emulate
Mimetas
uFluidix
Organovo
TissUse

Key Questions Addressed in this Report

What is the 10-year outlook for the global Microfluidic Devices For MPS (Microphysiological Systems) market?

What factors are driving Microfluidic Devices For MPS (Microphysiological Systems) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Microfluidic Devices For MPS (Microphysiological Systems) market opportunities vary by end market size?

How does Microfluidic Devices For MPS (Microphysiological Systems) break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

82 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Global by Company
4 World Historic Review for Microfluidic Devices For MPS (Microphysiological Systems) by Geographic Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Manufacturing Cost Structure Analysis
11 Marketing, Distributors and Customer
12 World Forecast Review for Microfluidic Devices For MPS (Microphysiological Systems) by Geographic Region
13 Key Players Analysis
14 Research Findings and Conclusion
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.